• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-PFO-025
Device Problem Unintended Movement (3026)
Patient Problem Embolism (1829)
Event Date 10/14/2019
Event Type  Injury  
Manufacturer Narrative
Product #1 pi main [pi-2019-0218774-01].Pi assign [pi-2019-0218774-01-01].Pi task [pi-2019-0218774-01-01-001.] the 25 mm amplatzer pfo occluder was received in the product performance engineering lab in a shipping container and was decontaminated.The occluder was grossly and microscopically examined, and no anomalies were found.It met dimensional specifications per drawing 90167768 revision h when measured with a caliper.Two measurements were taken of both the discs at two approximately perpendicular locations.The proximal disc measured 24.78 and 25.18 mm; and the distal disc measured 18.16 and 18.17 mm.The device was loaded into a test 8f loader and deployed.The proximal disc initially deployed in a bulbous formation.Light pressure was applied to the edges of the disc, which immediately reformed to proper conformation, meeting functional specifications.Product #1 pi main [pi-2019-0218774-01].An event of embolization after depolyment was reported.The investigation confirmed the device met functional and dimensional specifications when analyzed at abbott.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.The cause of the reported event could not be conclusively determined.
 
Event Description
A 25 mm amplatzer pfo occluder was selected for the procedure.The device was determined to be too small.It was reported that the device embolized after deployment and a snare was used to retrieve the device.No patient consequences reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
pamela yip
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key9261405
MDR Text Key166798457
Report Number2135147-2019-00359
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806011288
UDI-Public00811806011288
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 10/31/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date08/31/2024
Device Model Number9-PFO-025
Device Catalogue Number9-PFO-025
Device Lot Number7176873
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/14/2019
Initial Date FDA Received10/31/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/12/2019
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-